Definitive Contract FA301019CA011
- Not listed
- This is a federal contract award from the Air Education and Training Command (AETC), a defense agency, to Diagnostica Stago Inc., a foreign-owned, for-profit manufacturer of medical devices and consumables specializing in hemostasis and thrombosis testing technologies. The contract is for the lease of coagulation/hemostasis equipment, with a ceiling value of $110,880.00 and a period of performance ending on September 10, 2024. The contract is a delivery order under the GSA Schedule 66-III for...
- The Defense Health Agency awarded a $74,046.60 delivery order to Diagnostica Stago Inc. on September 11, 2024, for the lease of a coagulation hemostasis system with purchase of associated reagents. The contract is structured as a firm fixed price delivery order with an ultimate completion date of September 10, 2029, and will support clinical laboratory operations at Luke Air Force Base in Arizona. This award carries no set-aside designation and represents a continuation of the government's...
- The U.S. Air Force's Air Combat Command awarded a firm fixed price delivery order contract to Diagnostica Stago Inc., a foreign-owned for-profit manufacturer of medical devices and consumables for hemostasis and thrombosis testing. The $466,251.54 contract is for a 12-month base year lease of two coagulation analyzers with all supporting repair and preventative maintenance services provided by the contractor. The contract was awarded under Diagnostica Stago's existing GSA Schedule 66-III for...
- The Defense Health Agency awarded Diagnostica Stago Inc. a $363,547.14 delivery order on February 1, 2025, for coagulation analyzers and reagents to support clinical laboratory operations at Eglin Air Force Base, Florida. The contract, structured as a firm fixed-price delivery order under the GSA Schedule 66-III (Critical Analyzers, Laboratory Equipment and Supplies), extends through October 31, 2029. No set-aside designation was used in this award, reflecting open competition procurement....
- This is a firm fixed-price delivery order awarded by the Air Force Test Center to Diagnostica Stago Inc., a foreign-owned, for-profit manufacturer of medical devices and consumables specializing in hemostasis and thrombosis testing technologies. The $379,736.28 contract is for the delivery of coagulation analyzers to support clinical laboratory operations at Eglin Air Force Base in Florida. The contract is part of a larger Indefinite Delivery Vehicle (IDV) under GSA Schedule 66-III for...
- This federal contract award to Diagnostica Stago Inc. is for the lease of coagulation analyzers and associated supplies, including reagents and controls, to support clinical laboratory operations at U.S. Department of Defense (DOD) and Department of Veterans Affairs (VA) medical facilities. The $95,838.66 firm fixed price contract has an ultimate completion date of February 1, 2025 and was awarded on August 1, 2024 by the Defense Health Agency (DHA), a component of the DOD. The contract is not...
- The Defense Health Agency awarded a delivery order to Diagnostica Stago Inc. on August 21, 2024, for reagent rental fixed and reagent analysis services. This firm fixed price contract, valued at $1.12M, supports laboratory operations at the Defense Health Agency's Bethesda, Maryland facility through August 31, 2029. The award was made through open competition with no set-aside designation and is structured under the GSA Schedule 66-III for Critical Analyzers and Laboratory Equipment and...
- The Defense Health Agency awarded Diagnostica Stago Inc. a $1.17M firm fixed price purchase order on April 1, 2023, to supply hematology coagulation analyzers and reagents supporting the coagulation and special coagulation mission at Brooke Army Medical Center (BAMC) in Fort Sam Houston, Texas. The contract extends through February 29, 2028, and was awarded through open competition with no set-aside designation. Diagnostica Stago, a foreign-owned medical device manufacturer based in...
- This federal contract award to Diagnostica Stago UK LTD, a for-profit limited liability company based in the United Kingdom, provides coagulation reagents to support medical testing operations for the U.S. Air Forces Europe - Air Forces Africa (USAFE-AFAFRICA) command. The $8,703.61 firm-fixed-price delivery order has a period of performance through May 3, 2019. Diagnostica Stago UK LTD holds a single-award indefinite-delivery/indefinite-quantity (IDIQ) contract (FA558720D0004) with...
- This federal contract award is for the lease of a coagulation analyzer and associated equipment and services. The prime contractor is Diagnostica Stago Inc., a foreign-owned, for-profit manufacturer of medical devices and consumables specializing in hemostasis and thrombosis testing technologies. The contract, valued at $164,118.88, was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 7 on a firm fixed-price basis. The contract does not have a set-aside...
The Department of the Air Force Air Education and Training Command awarded a definitive contract valued at approximately $372,000 to Diagnostica Stago Inc. The contract provides for the lease of two coagulation analyzers and associated reagents, maintenance, training, and technical support services for the Keesler Medical Center located at Keesler Air Force Base in Mississippi. The period of performance is from January 2020 through September 2024. Per the original solicitation, the equipment lease and services are intended to eliminate specimen re-draws through use of electromechanical coagulation analyzers. There was no set-aside designation for this requirement. Funding is provided by the Air Force to support medical services at Keesler AFB.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Coagulation Testing (Includes Equip. Lease) | FA301019RA023 | Department of the Air Force Air Education and Training Command | Pre-Solicitation 1/1 | 8/5/19, 4:33 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00009 | Funding Only Action | $78.3k | 10/2/23 | |
| P00008 | Exercise an Option | $0 | 8/14/23 | |
| P00007 | Funding Only Action | $78.3k | 10/1/22 | |
| P00006 | Exercise an Option | $0 | 9/15/22 | |
| P00005 | Funding Only Action | $78.3k | 10/4/21 |